Reversible and irreversible protein glutathionylation: biological and clinical aspects

被引:118
|
作者
Cooper, Arthur J. L. [1 ]
Pinto, John T. [1 ]
Callery, Patrick S. [2 ]
机构
[1] New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA
[2] W Virginia Univ, Sch Pharm, Dept Basic Pharmaceut Sci, Morgantown, WV 26506 USA
关键词
busulfan; glutathione; glutathione disulfide; irreversible protein glutathionylation; lanthionine; redox potential; reversible protein glutathionylation; ALPHA-KETOGLUTARATE DEHYDROGENASE; HEPATIC VENOOCCLUSIVE-DISEASE; S-TRANSFERASE A1-1; OXIDATIVE STRESS; SULFENIC ACID; POSTTRANSLATIONAL MODIFICATION; QUANTITATIVE-DETERMINATION; RESPIRATORY BURST; SULFHYDRYL-GROUPS; BETA-ELIMINATION;
D O I
10.1517/17425255.2011.577738
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Introduction: Depending in part on the glutathione: glutathione disulfide ratio, reversible protein glutathionylation to a mixed disulfide may occur. Reversible glutathionylation is important in protecting proteins against oxidative stress, guiding correct protein folding, regulating protein activity and modulating proteins critical to redox signaling. The potential also exists for irreversible protein glutathionylation via Michael addition of an -SH group to a dehydroalanyl residue, resulting in formation of a stable, non-reducible thioether linkage. Areas covered: This article reviews factors contributing to reversible and irreversible protein glutathionylation and their biomedical implications. It also examines the possibility that certain drugs such as busulfan may be toxic by promoting irreversible glutathionylation. The reader will gain an appreciation of the protective nature and control of function resulting from reversible protein glutathionylation. The reader is also introduced to the recently identified phenomenon of irreversible protein glutathionylation and its possible deleterious effects. Expert opinion: The process of reversible protein glutathionylation is now well established but these findings need to be substantiated at the tissue and organ levels, and also with disease state. That being said, irreversible protein glutathionylation can also occur and this has implications in disease and aging. Toxicologists should consider this when evaluating the possible side effects of certain drugs such as busulfan that may generate a glutathionylating species in vivo.
引用
收藏
页码:891 / 910
页数:20
相关论文
共 50 条
  • [21] CLINICAL AND BIOLOGICAL ASPECTS OF MACROAMYLASEMIA
    KAMMERER, J
    EKINDJIAN, OG
    DUCHASSAING, D
    RAMIS, Y
    LELUAN, G
    FOUET, P
    ANNALES DE MEDECINE INTERNE, 1979, 130 (05): : 303 - 306
  • [22] Clinical and biological aspects of acromegaly
    Amani, M. El Amine
    DIABETES & METABOLISM, 2007, 33 : S104 - S104
  • [23] FIBRONECTIN - CLINICAL AND BIOLOGICAL ASPECTS
    KLINGEMANN, HG
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1982, 107 (36) : 1361 - 1365
  • [24] REVERSIBLE AND IRREVERSIBLE INHIBITION OF METABOLIC-ACTIVITY IN BIOLOGICAL PHOSPHORUS REMOVAL SYSTEMS
    CHIESA, SC
    POSTIGLIONE, JA
    LINNE, SR
    ENVIRONMENTAL TECHNOLOGY LETTERS, 1987, 8 (12): : 609 - 618
  • [25] Biological and clinical aspects of troponins
    Lefèvre, G
    ANNALES DE BIOLOGIE CLINIQUE, 2000, 58 (01) : 39 - 48
  • [26] BIOLOGICAL ASPECTS OF CLINICAL DERMATOLOGY
    FINDLAY, GH
    ARCHIVES OF DERMATOLOGY, 1962, 86 (04) : 393 - &
  • [27] APOPTOSIS - BIOLOGICAL AND CLINICAL ASPECTS
    BERGAMASCHI, G
    ROSTI, V
    DANOVA, M
    LUCOTTI, C
    CAZZOLA, M
    HAEMATOLOGICA, 1994, 79 (01) : 86 - 93
  • [28] Cryptococcosis: clinical and biological aspects
    Kwon-Chung, KJ
    Sorrell, TC
    Dromer, F
    Fung, E
    Levitz, SM
    MEDICAL MYCOLOGY, 2000, 38 : 205 - 213
  • [29] BIOLOGICAL AND CLINICAL ASPECTS OF BENZODIAZEPINES
    ZARIFIAN, E
    REVUE DU PRATICIEN, 1982, 32 (45-4): : 2887 - &
  • [30] CLINICAL AND BIOLOGICAL ASPECTS OF PHEOCHROMOCYTOMA
    MORNEX, R
    REVUE DU PRATICIEN, 1979, 29 (43): : 3291 - &